🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚀 We're heading to ASMS 2025! Stop by Booth #821 to meet our leadership and explore innovations in #massspectrometry & #proteomics. Connect with Tao Chen (CEO), Philip Lössl (SVP), Joy Zhou (Marketing Director). 📅 June 1–5 | 📍 Baltimore, USA 🏛️ Am Soc for Mass Spec #ASMS2025 #biotech

Halfway through #ASMS2025! Explore our N-15 proteins & MHC solutions at Booth #821 See how these tools are being used in proteomics research. Meet our team, join our 5-year anniversary prize draw, and connect with fellow scientists! 🧬🎉 #biotech #proteomics

🚨 Last poster session at #ASMS2025 is starting—final chance to visit Absea at Booth 821! Explore high-throughput proteomics, rigorously validated antibodies, with 70% human proteome coverage—empowering discovery at scale. 🎉 Prize winner announced at noon—stay tuned! #MassSpec

That’s a wrap on #ASMS2025! 🙌 Thanks to everyone who stopped by Absea’s booth—your insights inspired us! Top 3 talked-about tools: 🔹 15N-labeled proteins 🔹 MHC-targeting antibodies 🔹 IHC-validated antibodies Exciting 15N news on the horizon—stay tuned! 👀 #Proteomics #biotech

🧬 Tumor immune evasion: ↓ MHC I (up to 60%), PD-L1/CTLA-4, TGF-β/Tregs/MDSCs, Warburg/IDO1 ⚠️ Only 20–30%patients respond long-term to ICIs 🔬 Absea antibodies target these escape routes ➡️ Which mechanism are you tackling? #TumorImmunity #CancerResearch #Immunotherapy

🧪 Mass spectrometry drives proteomics research—but which mass spec application is most critical in your research? ✔️ Vote in the poll ✔️ Comment: What’s driving your choice? Any recent breakthroughs or challenges? #Proteomics #MassSpec

☀️ Celebrating our first official summer after works! Stepping outside the lab for some “sun” and laughs was a great way to recharge and strengthen the connections that drive our science at Absea. Looking forward to more shared moments!